Specialty Healthcare Consortium (SHC) Fall 2026 Conference

Oct 2 - Oct 4, 2026

  • Title: End Of Progression of Attack Manifestations With Oral Deucrictibant Immediate-Release Capsule for On-Demand Treatment of Hereditary Angioedema Attacks in the Phase 3 RAPIDe-3 Trial
    Presenter: Raffi Tachdjian, M.D., MPH.
    Format: E-Poster
    Date, time: Saturday, October 3, 9:30-10:30 a.m. CDT (8:30-9:30 a.m. EDT)
  • Title: In Silico Modeling of Human, Rat, and Humanized Rat Bradykinin B2 Receptor-Deucrictibant Complexes
    Format: Poster
    Date, time: Friday, October 2 – Sunday, October 4